Keith Boulware

Keith Boulware serves as a Contract Specialist within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic procurement of critical scientific and diagnostic capabilities. He manages complex acquisitions for laboratory equipment, in-vitro diagnostic systems, and biomedical research services, ensuring timely delivery of tools essential for infectious disease surveillance and public health response. His work directly enables CDC’s operational readiness by securing high-integrity technical solutions aligned with federal procurement regulations and public health priorities. Boulware maintains consistent procurement relationships with leading providers in the life sciences and public health sectors, including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid. These partnerships reflect a focus on high-capacity, technologically advanced vendors capable of delivering reliable diagnostic platforms, laboratory automation systems, and analytical instrumentation. His contracting approach emphasizes performance-based outcomes, compliance with federal standards, and long-term operational sustainability, fostering collaborative relationships with industry partners who meet stringent scientific and regulatory requirements. Boulware’s contracting portfolio reflects a strong preference for full and open competition, with 100% of awards issued under no set-aside conditions. This pattern indicates a focus on technical capability and mission-critical performance over socioeconomic preferences, prioritizing the most qualified vendors regardless of business size or certification status. While small business participation is not formally targeted, his acquisitions remain compliant with all applicable federal small business goals, and small businesses may participate as subcontractors within broader contract vehicles. His primary procurement focus centers on NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 325413 (In-Vitro Diagnostic Substance Manufacturing), reflecting deep expertise in laboratory diagnostics, clinical testing systems, and biomedical research infrastructure. He frequently procures automated nucleic acid analyzers, molecular diagnostic reagents, and laboratory information management systems, demonstrating specialized knowledge in public health laboratory operations and the regulatory frameworks governing medical device and diagnostic product acquisition.